ORAMED PHARMACEUTICALS INC
ORAMED PHARMACEUTICALS INC logo
ORMP

ORAMED PHARMACEUTICALS INC (ORMP)

$8.451.44%

Market is closed
– opens on 8 PM, 01 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$8.01
Day's Range
$8.48
$3.59
52-Week Range
$19.65
1 month return17.16%
3 month return1.65%
1 year return56.66%
5 year return28.62%

Company Information

Oramed Pharmaceuticals is a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, with offices in the United States and Israel, Oramed has developed a novel Protein Oral Delivery (POD™) technology. Oramed is seeking to revolutionize the treatment of diabetes through its proprietary lead candidate, ORMD-0801, which has the potential to be the first commercial oral insulin capsulefor the treatment of diabetes. The Company has completed multiple Phase II clinical trials under an Investigational New Drug application with the U.S. Food and Drug Administration. In addition, Oramed is developing an oral GLP-1 (Glucagon-like peptide-1) analog capsule, ORMD-0901.
OrganizationORAMED PHARMACEUTICALS INC
Employees0
CEOMr. Nadav Kidron Esq.
IndustryHealth Technology

Analyst Recommendation

based on 4 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 4 Wall street analysts offering stock ratings for ORAMED PHARMACEUTICALS INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 239.29%

Current

$8.45

Target

$28.67

Recommendation Trend

Based on 4 analyst

Current1M Ago3M Ago
Buy
4
10
9
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
325.8M
Book Value
$3.93
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-1.0
PEG Ratio
0.0
Wall Street Target Price
28.67

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
2.03
Enterprise Value
153.1M
Enterprise Value/Revenue
56.64
Enterprise Value/Ebitda
-5.78

Technicals

Beta
2.28
50 Day MA
6.96
200 Day MA
7.3

Institutional Holdings

Two Sigma Advisers, LLC

1.74%

Citadel Advisors Llc

1.66%

Two Sigma Investments LLC

1.64%

Millennium Management LLC

1.48%

Morgan Jess S & CO Inc

0.94%

Renaissance Technologies Corp

0.92%

Discover more

Frequently Asked Questions

What is ORAMED PHARMACEUTICALS INC share price today?

Can Indians buy ORAMED PHARMACEUTICALS INC shares?

How can I buy ORAMED PHARMACEUTICALS INC shares from India?

Can Fractional shares of ORAMED PHARMACEUTICALS INC be purchased?

What are the documents required to start investing in ORAMED PHARMACEUTICALS INC stocks?

What are today’s High and Low prices of ORAMED PHARMACEUTICALS INC?

What are today’s traded volumes of ORAMED PHARMACEUTICALS INC?

What is today’s market capitalisation of ORAMED PHARMACEUTICALS INC?

What is the 52 Week High and Low Range of ORAMED PHARMACEUTICALS INC?

How much percentage ORAMED PHARMACEUTICALS INC is down from its 52 Week High?

How much percentage ORAMED PHARMACEUTICALS INC is up from its 52 Week low?

What are the historical returns of ORAMED PHARMACEUTICALS INC?

Who is the Chief Executive Officer (CEO) of ORAMED PHARMACEUTICALS INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*